Literature DB >> 28885772

Overt hepatic encephalopathy impairs learning on the EncephalApp stroop which is reversible after liver transplantation.

Chathur Acharya1, James B Wade2, Andrew Fagan1, Melanie White1, Edith Gavis1, Dinesh Ganapathy1, HoChong Gilles1, Douglas M Heuman1, Jasmohan S Bajaj1.   

Abstract

After an initial exposure, patients can develop test-taking/learning strategies called the "test sophistication effect." Patients with cirrhosis with prior overt hepatic encephalopathy (OHE) could have persistent learning impairments. The aim was to define learning/test sophistication on EncephalApp (downloadable application) in OHE patients compared with patients without prior overt hepatic encephalopathy (no-OHE) patients and controls cross-sectionally and longitudinally. The EncephalApp Stroop App consists of 2 sections: the easier "Off" run assesses psychomotor speed while the difficult "On" run assesses cognitive flexibility. For the cross-sectional analysis, outpatients with cirrhosis with/without controlled OHE and healthy controls underwent EncephalApp testing, which requires 5 Off and 5 On runs. We studied the difference in time required between completing trial 1 compared with trial 5 (delta 1-5) in both the On and Off runs in controls, all patients with cirrhosis, and between prior OHE/no-OHE patients with cirrhosis. For the longitudinal analyses, 2 groups of patients with cirrhosis were studied; 1 was administered the EncephalApp ≥ 2 weeks apart, and the second was administered before and 6 months after liver transplantation. The study included 89 controls and 230 patients with cirrhosis (85 prior OHE; Model for End-Stage Liver Disease, 11) with similar age (64 versus 61 years; P = 0.92). Patients with cirrhosis had impaired EncephalApp total times and impaired learning on the On runs compared with controls. OHE patients had worse EncephalApp times and learning with the On runs compared with no-OHE patients, which persisted in the longitudinal cohort. No differences in learning were seen in the Off runs. After transplant, there was restoration of learning capability with the On runs in the OHE patients. In conclusion, cognitive flexibility tested by the EncephalApp On runs improves over time in healthy controls and no-OHE but not prior OHE. Psychomotor speed remains similar over time. The learning impairment manifested by patients with cirrhosis with OHE is restored after transplant. Liver Transplantation 23 1396-1403 2017 AASLD.
© 2017 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2017        PMID: 28885772      PMCID: PMC5739053          DOI: 10.1002/lt.24864

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  28 in total

1.  fMri studies of Stroop tasks reveal unique roles of anterior and posterior brain systems in attentional selection.

Authors:  M T Banich; M P Milham; R Atchley; N J Cohen; A Webb; T Wszalek; A F Kramer; Z P Liang; A Wright; J Shenker; R Magin
Journal:  J Cogn Neurosci       Date:  2000-11       Impact factor: 3.225

2.  Oxidative stress markers in the brain of patients with cirrhosis and hepatic encephalopathy.

Authors:  Boris Görg; Natalia Qvartskhava; Hans-Jürgen Bidmon; Nicola Palomero-Gallagher; Gerald Kircheis; Karl Zilles; Dieter Häussinger
Journal:  Hepatology       Date:  2010-07       Impact factor: 17.425

3.  Hepatic encephalopathy expands the predictivity of model for end-stage liver disease in liver transplant setting: Evidence by means of 2 independent cohorts.

Authors:  Cristina Lucidi; Stefano Ginanni Corradini; Juan G Abraldes; Manuela Merli; Puneeta Tandon; Flaminia Ferri; Lucia Parlati; Barbara Lattanzi; Edoardo Poli; Vincenza Di Gregorio; Alessio Farcomeni; Oliviero Riggio
Journal:  Liver Transpl       Date:  2016-10       Impact factor: 5.799

4.  Practice effect and test-retest reliability of attentional and executive tests in middle-aged to elderly subjects.

Authors:  Simon Lemay; Marc-André Bédard; Isabelle Rouleau; Pierre-Luc Gilbert Tremblay
Journal:  Clin Neuropsychol       Date:  2004-05       Impact factor: 3.535

5.  Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver.

Authors:  Hendrik Vilstrup; Piero Amodio; Jasmohan Bajaj; Juan Cordoba; Peter Ferenci; Kevin D Mullen; Karin Weissenborn; Philip Wong
Journal:  Hepatology       Date:  2014-07-08       Impact factor: 17.425

6.  Cerebral cortical and white matter lesions in chronic hepatic encephalopathy: MR-pathologic correlations.

Authors:  Eiji Matsusue; Toshibumi Kinoshita; Eisaku Ohama; Toshihide Ogawa
Journal:  AJNR Am J Neuroradiol       Date:  2005-02       Impact factor: 3.825

Review 7.  Review article: the design of clinical trials in hepatic encephalopathy--an International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) consensus statement.

Authors:  J S Bajaj; J Cordoba; K D Mullen; P Amodio; D L Shawcross; R F Butterworth; M Y Morgan
Journal:  Aliment Pharmacol Ther       Date:  2011-02-09       Impact factor: 8.171

8.  Evidence of persistent cognitive impairment after resolution of overt hepatic encephalopathy.

Authors:  Oliviero Riggio; Lorenzo Ridola; Chiara Pasquale; Silvia Nardelli; Ilaria Pentassuglio; Federica Moscucci; Manuela Merli
Journal:  Clin Gastroenterol Hepatol       Date:  2010-10-15       Impact factor: 11.382

9.  Liver transplantation significantly improves global functioning and cerebral processing.

Authors:  Vishwadeep Ahluwalia; James B Wade; Melanie B White; HoChong S Gilles; Douglas M Heuman; Michael Fuchs; Edith A Gavis; Andrew Fagan; Felicia Tinsley; Dinesh Ganapathy; Leroy R Thacker; Richard K Sterling; R Todd Stravitz; Puneet Puri; Arun J Sanyal; Muhammad S Siddiqui; Scott Matherly; Velimir Luketic; Joel Steinberg; F Gerard Moeller; Jasmohan S Bajaj
Journal:  Liver Transpl       Date:  2016-10       Impact factor: 5.799

10.  Impaired Gut-Liver-Brain Axis in Patients with Cirrhosis.

Authors:  Vishwadeep Ahluwalia; Naga S Betrapally; Phillip B Hylemon; Melanie B White; Patrick M Gillevet; Ariel B Unser; Andrew Fagan; Kalyani Daita; Douglas M Heuman; Huiping Zhou; Masoumeh Sikaroodi; Jasmohan S Bajaj
Journal:  Sci Rep       Date:  2016-05-26       Impact factor: 4.379

View more
  3 in total

Review 1.  Psychometric methods for diagnosing and monitoring minimal hepatic encephalopathy -current validation level and practical use.

Authors:  Mads Kingo Guldberg Hansen; Kristoffer Kjærgaard; Lotte Lindgreen Eriksen; Lea Ladegaard Grønkjær; Anne Catrine Daugaard Mikkelsen; Thomas Damgaard Sandahl; Hendrik Vilstrup; Karen Louise Thomsen; Mette Munk Enok Lauridsen
Journal:  Metab Brain Dis       Date:  2022-02-01       Impact factor: 3.584

2.  Cognitive Impairment After Resolution of Hepatic Encephalopathy: A Systematic Review and Meta-Analysis.

Authors:  Óscar López-Franco; Jean-Pascal Morin; Albertina Cortés-Sol; Tania Molina-Jiménez; Diana I Del Moral; Mónica Flores-Muñoz; Gabriel Roldán-Roldán; Claudia Juárez-Portilla; Rossana C Zepeda
Journal:  Front Neurosci       Date:  2021-03-10       Impact factor: 4.677

3.  High-Fat Diet Modulates Hepatic Amyloid β and Cerebrosterol Metabolism in the Triple Transgenic Mouse Model of Alzheimer's Disease.

Authors:  Cristina R Bosoi; Milène Vandal; Marine Tournissac; Manon Leclerc; Hortense Fanet; Patricia L Mitchell; Mélanie Verreault; Jocelyn Trottier; Jessica Virgili; Cynthia Tremblay; H Robert Lippman; Jasmohan S Bajaj; Olivier Barbier; André Marette; Frédéric Calon
Journal:  Hepatol Commun       Date:  2020-12-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.